PSME3IP1 and osteoporosis: In this study, we investigated the role of REGγ in osteoporosis in detail, demonstrating that REGγ could be a potential predictive biomarker for the early diagnosis and modulation of REGγ activity by interfering with NIP30-REGγ interactions, which may provide unique venues for the development of pharmacological agents.